Cotargeting Plk1 and androgen receptor enhances the therapeutic sensitivity of paclitaxel-resistant prostate cancer - Sol-Bi Shin, Sang-Uk Woo, Hyungshin Yim, 2019
![And Now, the Most Instagrammable Sandals Just in Time for Spring (WhoWhatWear.com) | Slingback sandal, Jacquemus, Sandals And Now, the Most Instagrammable Sandals Just in Time for Spring (WhoWhatWear.com) | Slingback sandal, Jacquemus, Sandals](https://i.pinimg.com/474x/70/00/45/700045c34e21f96b05f709ae96b76a69.jpg)
And Now, the Most Instagrammable Sandals Just in Time for Spring (WhoWhatWear.com) | Slingback sandal, Jacquemus, Sandals
![Cotargeting Plk1 and androgen receptor enhances the therapeutic sensitivity of paclitaxel-resistant prostate cancer - Sol-Bi Shin, Sang-Uk Woo, Hyungshin Yim, 2019 Cotargeting Plk1 and androgen receptor enhances the therapeutic sensitivity of paclitaxel-resistant prostate cancer - Sol-Bi Shin, Sang-Uk Woo, Hyungshin Yim, 2019](https://journals.sagepub.com/cms/10.1177/1758835919846375/asset/images/large/10.1177_1758835919846375-fig7.jpeg)
Cotargeting Plk1 and androgen receptor enhances the therapeutic sensitivity of paclitaxel-resistant prostate cancer - Sol-Bi Shin, Sang-Uk Woo, Hyungshin Yim, 2019
![Cotargeting Plk1 and androgen receptor enhances the therapeutic sensitivity of paclitaxel-resistant prostate cancer - Sol-Bi Shin, Sang-Uk Woo, Hyungshin Yim, 2019 Cotargeting Plk1 and androgen receptor enhances the therapeutic sensitivity of paclitaxel-resistant prostate cancer - Sol-Bi Shin, Sang-Uk Woo, Hyungshin Yim, 2019](https://journals.sagepub.com/cms/10.1177/1758835919846375/asset/images/large/10.1177_1758835919846375-fig3.jpeg)